LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

Feb 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-02-11

Reporting Person: WADE JEFFREY L (EVP, Corp Adm Affairs and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-11	Restricted Stock Units	$	A	33530	Acquired		Common Stock (33530)	Direct
2021-02-11	Stock Option (Right to Buy)	$8.38	A	100600	Acquired	2031-02-11	Common Stock (100600)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.